USE OF METABOLIC PHENOTYPING IN INDIVIDUALIZED TREATMENT WITH AMONAFIDE

Details for Australian Patent Application No. 2002242499 (hide)

Owner MCGILL UNIVERSITY

Inventors LEYLAND-JONES, Brian

Pub. Number AU-A-2002242499

PCT Pub. Number WO2002/071060

Priority 60/271,714 28.02.01 US

Filing date 28 February 2002

Wipo publication date 19 September 2002

International Classifications

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

13 March 2003 Application Open to Public Inspection

  Published as AU-A-2002242499

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002242500-CATHEPSIN CYSTEINE PROTEASE INHIBITORS

2002242498-LINEAR NUCLEIC ACID SEQUENCE COMPRISING REPEATS AND LACKING SECONDARY STRUCTURE